医学
置信区间
优势比
内科学
体质指数
范畴变量
前瞻性队列研究
肌萎缩
逻辑回归
流行病学
地中海饮食法
可能性
混淆
梅德林
队列研究
索引(排版)
老年学
膳食补充剂
回归分析
饮食管理
荟萃分析
作者
Héctor Vázquez‐Lorente,Héctor Gil-Vidal,Francesc Calabuig-Montroy,Ángel Domingo-Martínez,Julio Plaza‐Díaz,Jordi Salas‐Salvadó
标识
DOI:10.1080/10408398.2026.2763295
摘要
Dietary inflammatory potential may be associated with sarcopenia, but evidence is heterogeneous. We systematically reviewed associations of the Dietary Inflammatory Index (DII) and energy-adjusted DII (E-DII) with sarcopenia-related outcomes in adults. PubMed, Embase, and Web of Science were searched through 31 August 2026. Random-effects meta-analyses prioritized confirmed sarcopenia. Forty-seven eligible studies were included; 16 contributed to quantitative syntheses and six were prospective. In eight cross-sectional studies, the highest versus lowest DII/E-DII category was associated with greater odds of confirmed sarcopenia (OR = 1.75, 95% CI 1.37–2.24; I2=38.5%; 95% prediction interval 1.03–2.99). Four studies contributed to per-unit analysis (OR = 1.37, 95% CI 1.25–1.51; I2=0%; prediction interval 1.12–1.68). Component-specific evidence extended to muscle strength and physical performance. Exploratory Egger regression indicated funnel-plot asymmetry; trim-and-fill attenuated the primary categorical OR to 1.48 (95% CI 1.24–1.77) and the broad categorical OR to 1.53 (95% CI 1.34–1.76). Certainty was very low. Greater dietary inflammatory potential was associated with confirmed sarcopenia, but predominantly cross-sectional evidence, heterogeneous longitudinal findings, and potential small-study effects limit causal interpretation. Clinical application is premature; prospective cohorts with repeated dietary assessment and standardized outcomes, and intervention trials, are needed.
科研通智能强力驱动
Strongly Powered by AbleSci AI